ResMed
RMD
351 hedge funds and large institutions have $4.44B invested in ResMed in 2015 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 111 increasing their positions, 121 reducing their positions, and 17 closing their positions.
241% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 17
55% more call options, than puts
Call options by funds: $15.3M | Put options by funds: $9.86M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
13% more capital invested
Capital invested by funds: $3.92B → $4.44B (+$515M)
12% more funds holding
Funds holding: 313 → 351 (+38)
4.24% more ownership
Funds ownership: 55.08% → 59.32% (+4.2%)
8% less repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 121
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$348M |
| 2 |
Goldman Sachs
New York
|
+$40.8M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$35.8M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$33.9M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$17.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$114M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$70.2M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$24.1M |
| 4 |
Millennium Management
New York
|
-$15.5M |
| 5 |
Two Sigma Investments
New York
|
-$11.8M |
RMD Hedge Fund Activity: Q4 2015 in Review
351 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q4 2015, worth a combined $4.44B — up 13% from $3.92B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new RMD positions and 17 closed out — a net gain of 41 holders — while 111 added to existing stakes and 121 trimmed.
The largest buyer was Capital World Investors, opening a new position worth an estimated $348M. The largest seller was Capital Research Global Investors, cutting an estimated $114M.
- 351 institutional investors held ResMed (RMD) as of Q4 2015, up from 313 in Q3 2015.
- Funds reported $4.44B of ResMed stock for Q4 2015, up 13% quarter-over-quarter.
- 58 funds opened new ResMed positions in Q4 2015 and 17 closed out, a net change of +41 holders.
- The largest ResMed buyer in Q4 2015 was Capital World Investors, an estimated $348M added.
- The largest ResMed seller in Q4 2015 was Capital Research Global Investors, an estimated $114M sold.
Based on aggregated 13F filings for Q4 2015.